Karyopharm Therapeutics
KPTI
KPTI
78 hedge funds and large institutions have $704M invested in Karyopharm Therapeutics in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% more funds holding
Funds holding: 60 → 78 (+18)
Holders
78
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$104M | |
| 2 | +$49.7M | |
| 3 | +$16.4M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$12.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.11M |
Top Sellers
| 1 | -$9.7M | |
| 2 | -$2.08M | |
| 3 | -$1.98M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.97M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.76M |